GLENDALE, Calif., May 16, 2012 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-AMEH.PK) announced financial results for its fiscal year ended January 31, 2012.
Fiscal Year 2012 Financial Highlights:
- Net revenue increased 31.2% to $5.1 million for the fiscal year ended January 31, 2012 compared to $3.9 million in the fiscal year ended January 31, 2011
- Gross profit increased 68.1% to $978,407 for the fiscal year ended January 31, 2012 compared to $581,862 in the fiscal year ended January 31, 2011
- Operating (loss) income was ($413,335) for the fiscal year ended January 31, 2012 compared to $4,015 in the fiscal year ended January 31, 2011
- Non-GAAP Adjusted EBITDA increased 33.6% was $181,401 for the fiscal year ended January 31, 2012 compared to $135,740 in the fiscal year ended January 31, 2011
Other Highlights:
- Added 3 new hospital contracts during the year, bringing total number to six
- Contracted with 3 health plans to provide inpatient care for its members at 23 hospitals
- Acquired Pulmonary Critical Care Management Inc. to expand our ICU management service offering
- 2 new Board members were added to increase governance
"ApolloMed has again generated record net revenues for the year," stated Warren Hosseinion, M.D. Chief Executive Officer. "We continue to execute on our growth strategy on all fronts, including expanding our geographic footprint and adding new hospital, medical group and health plan clients. We are seeing more demand for our hospitalist, critical care and multi-disciplinary care management services as all participants in the healthcare delivery chain look to improve metrics and reduce unnecessary costs. We are investing in our infrastructure to create a company geared for expansion. We are confident in the ongoing direction of ApolloMed and will continue to look for new growth opportunities to leverage our excellent care management product offering."
APOLLO MEDICAL HOLDINGS, INC. CONSOLIDATED BALANCE SHEETS FOR THE YEARS ENDED JANUARY 31, 2012 AND 2011 | |||||||
January 31, | |||||||
2012 | 2011 | ||||||
CURRENT ASSETS | |||||||
Cash and cash equivalents | $ | 164,361 | $ | 397,101 | |||
Accounts receivable, net | 994,118 | 704,971 | |||||
Advances | 2,140 | - | |||||
Receivable from officers | - | 24,873 | |||||
Due from affiliate | 5,504 | 3,900 | |||||
Prepaid expenses | 45,601 | 29,138 | |||||
Prepaid financing cost, current | 37,500 | 37,500 | |||||
Total current assets | 1,249,224 | 1,197,483 | |||||
Prepaid financing cost, long term | 1,563 | 39,500 | |||||
Property and equipment - net | 43,261 | 21,593 | |||||
Intangible assets | 38,000 | - | |||||
Goodwill | 32,000 | - | |||||
TOTAL ASSETS | $ | 1,364,048 | $ | 1,258,139 | |||
LIABILITIES AND STOCKHOLDERS' DEFICIT: | |||||||
CURRENT LIABILITIES: | |||||||
Accounts payable and accrued liabilities | $ | 163,476 | $ | 92,745 | |||
Convertible notes, net of $653,026 debt discount | 596,366 | - | |||||
Derivative liability | 653,026 | - | |||||
Shares to be issued | 90,000 | - | |||||
Due to officers | 12,400 | - | |||||
Total current liabilities | 1,515,268 | 92,745 | |||||
Convertible notes | 150,000 | 1,248,588 | |||||
Warrant liability | 120,000 | - | |||||
Total liabilities | 1,785,268 | 1,341,333 | |||||
STOCKHOLDERS' DEFICIT: | |||||||
Preferred stock, par value $0.001 ;5,000,000 shares authorized; none issued | - | - | |||||
Common Stock, par value $0.001; 100,000,000 shares authorized,29,335,774 and 27,635,774 shares issued and outstanding as on January 31, 2012 and 2011, respectively | 29,336 | 27,636 | |||||
Additional paid-in-capital | 1,429,051 | 1,058,418 | |||||
Accumulated deficit | (2,117,708) | (1,397,363) | |||||
Total | (659,321) | (311,309) | |||||
Non-controlling interest | 238,101 | 228,115 | |||||
Total stockholders' deficit | (421,220) | (83,194) | |||||
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ | 1,364,048 | $ | 1,258,139 | |||
APOLLO MEDICAL HOLDINGS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED JANUARY 31, 2012 AND 2011 | |||||||
Fortheyearsended | |||||||
January31, | |||||||
2012 | 2011 | ||||||
REVENUES | $ | 5,110,806 | $ | 3,896,584 | |||
COST OF SERVICES | 4,132,399 | 3,314,722 | |||||
GROSS PROFIT | 978,407 | 581,862 | |||||
Operating expenses: | |||||||
General and administrative | 1,379,153 | 566,649 | |||||
Depreciation | 12,589 | 11,198 | |||||
Total operating expenses | 1,391,742 | 577,847 | |||||
(LOSS) INCOME FROM OPERATIONS | (413,335) | 4,015 | |||||
OTHER EXPENSES: | |||||||
Interest expense | (131,534) | (126,431) | |||||
Financing cost | (172,500) | (37,500) | |||||
Other income | 2,842 | 5,185 | |||||
Total other expenses | (301,192 | 158,746 | |||||
LOSS BEFORE INCOME TAXES | (714,527) | (154,731) | |||||
Provision for income tax | 5,819 | 1,600 | |||||
NET LOSS | $ | (720,346) | $ | (156,331) | |||
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED | 29,078,925 | 27,490,476 | |||||
*BASIC AND DILUTED NET LOSS PER SHARE | $ | (0.02) | $ | (0.01) | |||
*Weighted average number of shares used to compute basic and diluted loss per share is the same since the effect of dilutive securities is anti-dilutive.
APOLLO MEDICAL HOLDINGS, INC. RECONCILIATION OF OPERATING INCOME TO ADJUSTED EBITDA FOR THE YEARS ENDED JANUARY 31, 2012 AND 2011 | |||||||
Fortheyearsended | |||||||
January31, | |||||||
2012 | 2011 | ||||||
(LOSS) INCOME FROM OPERATIONS | $ | (413,335) | $ | 4,015 | |||
Depreciation | 12,589 | 11,198 | |||||
EBITDA | (400,746) | 15,204 | |||||
Issuance of shares for service | 152,400 | 47,378 | |||||
Stock option expense | 29,333 | 72,152 | |||||
Amortization of debt discount | 804 | 1,006 | |||||
Impairment loss | 210,000 | ||||||
Loss from discontinued operations | 189,610 | ||||||
ADJUSTED EBITDA | $ | 181,401 | $ | 135,740 | |||
*Use of Non-GAAP Financial Measures
In addition to containing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), this press release also contains non-GAAP financial measures. Adjusted EBITDA, as used in this press release, represents (Loss) Income from Operations before depreciation, adjusted for issuance of shares for service, stock option expense, amortization of debt discount and impairment of intangibles and losses on discontinued operations. Adjusted EBITDA is a key indicator used by management to evaluate operating performance. While adjusted EBITDA is not intended to replace any presentation included in the consolidated financial statements under GAAP and should not be considered an alternative to operating performance or an alternative to cash flow as a measure of liquidity, the Company believes this measure is useful to investors in assessing the Company's ongoing operating performance and working capital requirements. This calculation may differ in method of calculation from similarly titled measures used by other companies. A reconciliation of adjusted EBITDA to the nearest comparable GAAP financial measure is included in the financial schedules accompanying this press release. The Non-GAAP financial measures, as well as other information in this press release, should be read in conjunction with the Company's financial statements filed with the Securities and Exchange Commission.
About Apollo Medical Holdings, Inc.
ApolloMed is a leading provider of integrated medical management services that improves the quality and efficiency of inpatient hospital care plus multi-disciplinary care management services targeting inefficiencies in healthcare payer and provider networks. The Company's integrated model combines hospitalist medicine, critical care medicine, 24-hour physician call centers, case management and transition management that offers to help healthcare organizations engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. The company's strategy is to capitalize on the growing market for hospital-based physicians and care management services.
Media Contact:
Nidia Flores
818-396-8050
SOURCE Apollo Medical Holdings, Inc.
